Zimbabwe’s proposed overhaul of medical aid regulations is shaping into one of the most consequential health policy battles in years. Medical aid societies warn that forcing them to sell off clinics, hospitals and specialist units could wipe out more than 10,000 jobs, erase over US$200 million in health investments, and push thousands of patients back into an already overwhelmed public system. The proposed changes are contained in amendments to the Medical Aid Societies Regulations.
At the centre of the storm is a proposed rewrite of Section 14, which would outlaw what government calls “vertical integration” — the model under which medical aid societies both finance healthcare and own service delivery assets such as clinics, hospitals, pharmacies and laboratories. Stakeholders say the amendment must be halted or substantially reworked to avoid jeopardising jobs, investment and access to affordable healthcare.
The draft amendment is sweeping. It bars any medical aid society, subsidiary, associated entity or related party from owning, managing, operating or holding a financial interest in a healthcare provider, private hospital, specialist unit or facility. Existing operators would have six months to submit divestiture plans and no more than 36 months to dispose of all such assets. Any deal that leaves societies with continued influence or indirect control would be rejected. 
For medical aid societies, this is not a technical compliance issue. It is a direct threat to infrastructure they say has helped keep healthcare affordable in an unstable market.
In a joint position paper submitted to the Ministry of Health and Child Care on 5 March, major players including First Mutual Health, CIMAS, PSMAS, Vivat and Parkmed warned that the blanket ban, in its current form, risks undermining affordability, access and the wider resilience of Zimbabwe’s healthcare system.
Their core argument is simple: society-owned facilities were built not to entrench monopolies, but to shield members from runaway private sector costs, unpredictable tariffs and treatment delays.
“Over time, societies invested in health facilities to protect affordability and availability of care,” reads one stakeholder submission.
“In many cases, private providers charge above what societies can sustainably pay… Society-run facilities reduce that uncertainty. They also mean we are not always price-takers at the mercy of independent private facilities.” 
Stakeholders also argue that a critical point has been missed: the real owners of many of these healthcare assets are the members themselves. For years, workers, pensioners and families have pooled monthly contributions to build and sustain clinics, hospitals and specialist units designed to guarantee quality care for themselves, their dependants and, increasingly, the wider public.
The likely fallout from forced closures or distressed sales, stakeholders say, would be immediate: higher subscriptions, larger out-of-pocket costs, delayed treatment, disrupted chronic care, reduced access to medicines, and the loss of thousands of skilled and semi-skilled jobs.
That warning carries added weight in Zimbabwe, where the public health system is already buckling under chronic medicine shortages, staff deficits, long queues and ageing infrastructure.
Ironically, the current regulations already recognise the central role of public hospitals and state-aided clinics by making them the baseline for minimum benefit cover. But medical aid societies argue public institutions simply do not have the capacity to absorb a sudden influx of patients if society-run facilities are dismantled. 
This matters in a country where less than 5% of the population is formally covered by medical aid.
For that small but critical group — civil servants, pensioners, workers on lower-tier packages and their families — society-owned facilities often provide the only dependable route to affordable treatment.
As one stakeholder paper notes, members pool limited monthly contributions precisely because illness is unpredictable. Society-run facilities help stretch those pooled funds and deliver care when it is needed. Strip away that infrastructure, and the burden shifts back to patients already stretched to breaking point. 
The economic consequences could be just as severe.
Medical aid societies say they have collectively invested more than US$200 million in health infrastructure over the years — clinics, pharmacies, laboratories, specialist centres and support systems built over decades. Forcing divestiture under rigid timelines could trigger fire-sale disposals, destroy asset value, chill future health investment and wipe out more than 10,000 direct and indirect jobs across healthcare, administration, logistics, maintenance and supply chains.
But the deeper risk lies beyond the balance sheet.
In a healthcare market already plagued by tariff disputes, delayed reimbursements and widespread shortfalls, society-owned facilities have acted as a stabilising buffer. Remove them, and many medical aid members could be pushed into a fragmented private market where cash top-ups become routine — or where treatment is delayed because they simply cannot afford the gap.
That is the central contradiction in the proposed amendment: a reform framed as a clean-up of conflicts of interest could end up dismantling one of the few functioning cushions in Zimbabwe’s healthcare system.
Without a realistic transition plan, this policy may not just hurt medical aid societies. It could hurt the very patients government says it wants to protect.
